JW SHINYAK CORPORATION
A pharmaceutical company supplying antifungal and urology drugs to clinics, co-marketing original drugs together with JW Pharmaceutical.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1981 and listed on KOSDAQ in 2003, JW Shinyak is a pharmaceutical company focused on manufacturing and selling medicines. It supplies antifungal agents and urology drugs to hospitals, clinics, and pharmacies, targeting the internal medicine market and clinic markets such as dermatology, pediatrics, urology, and otolaryngology, building its sales network through co-marketing of original drugs with JW Pharmaceutical. In 2025 it recorded consolidated revenue of KRW 81.0 billion and operating profit of KRW 7.5 billion, while its subsidiary JW Creagene completed liquidation on October 1, 2025.
Products & technology
- Antifungal agentsFungal infection treatment
- Urology drugsUrological disease treatment
Regulatory approvals
data.go.kr182 Korean MFDS drug approvals · 1986–2026 / 2 Korean MFDS device approvals · 2004
- MFDS drugMinoxphase 2.5mg Tablet2026-02-27Drug · Prescription · Approval202600618
- MFDS drugMinoxphase 5mg Tablet2026-02-11Drug · Prescription · Approval202600392
- MFDS drugDORANEX Cap. (Tranexamic acid)2026-01-12Drug · Prescription · Approval202600108
- MFDS drugESIPLE-N DUO Cap.2025-10-10Drug · OTC · Notification202502627
- MFDS drugMYDIL 5% Foam Aerosol2024-08-02Drug · OTC · Notification202401884
- MFDS drugEPINAIL topical solution (Efinaconazole)2024-07-08Drug · Prescription · Approval202401663
- MFDS drugDecne Cream2024-06-28Drug · Prescription · Approval202401575
- MFDS drugPD Tab. 2mg2023-11-21Drug · Prescription · Approval202303175
- MFDS drugGinkgoturn Tab. 240mg2023-09-11Drug · OTC · Notification202302694
- MFDS drugJADI-M DUO 12.5/500mg2023-09-01Drug · Prescription · Approval202302605
- MFDS drugJADI-M DUO 12.5/1000mg2023-09-01Drug · Prescription · Approval202302606
- MFDS drugJADI-M DUO 12.5/850mg2023-09-01Drug · Prescription · Approval202302607
Show 68 more
- MFDS drugWilpower Focus Sol.2023-02-28Drug · OTC · Notification202300723
- MFDS drugBestidine Tab. 40mg (Famotidine)2023-02-28Drug · Prescription · Approval202300724
- MFDS drugDUALTERA Tablet 60/5mgRevoked2023-01-06Drug · Prescription · Approval202300094
- MFDS drugDUALTERA Tablet 30/2.5mgRevoked2023-01-06Drug · Prescription · Approval202300134
- MFDS drugIBUFEPHEN inj.2022-04-28Drug · Prescription · Approval202201731
- MFDS drugJADI-M DUO Tab. 5/1000mg2022-04-04Drug · Prescription · Approval202201339
- MFDS drugJADI-M DUO Tab. 5/850mg2022-04-04Drug · Prescription · Approval202201340
- MFDS drugJADI-M DUO Tab. 5/500mg2022-04-04Drug · Prescription · Approval202201341
- MFDS drugROCUDION Inj. (Sugammadex Sodium)2022-03-11Drug · Prescription · Approval202201035
- MFDS drugBEBIUM Syrup. (Lactulose Concentrate)2022-01-13Drug · OTC · Notification202200245
- MFDS drugBESDUO Tab. 20/800mg2021-06-18Drug · Prescription · Approval202104747
- MFDS drugJADI-M Tab. 25mg (Empagliflozin)Revoked2021-03-05Drug · Prescription · Approval202102043
- MFDS drugJADI-M Tab. 10mg(Empagliflozin)Revoked2021-03-05Drug · Prescription · Approval202102044
- MFDS drugTAMIGA SR tab. (Mirabegron)2021-02-18Drug · Prescription · Approval202101475
- MFDS drugAuszet tab. 10/20mg2021-02-18Drug · Prescription · Approval202101605
- MFDS drugAuszet tab. 10/10mg2021-02-18Drug · Prescription · Approval202101606
- MFDS drugAuszet tab. 10/40mg2021-02-18Drug · Prescription · Approval202101607
- MFDS drugWELLMACO MINI soft cap. 2g (Omega-3-Acid Ethyl Esters 90)2020-03-11Drug · Prescription · Approval202001697
- MFDS drugMONAKHAN Tab.2020-02-28Drug · Prescription · Approval202001433
- MFDS drugJ Down Cap. 120mg2020-02-10Drug · Prescription · Approval202000759
- MFDS drugJ Down Cap. 60mg2020-02-10Drug · Prescription · Approval202000760
- MFDS drugGLICOVER Syrup (Choline Alfoscerate)Revoked2019-08-21Drug · Prescription · Notification201905919
- MFDS drugBESTICON Soft Cap.Revoked2019-07-12Drug · Prescription · Notification201904711
- MFDS drugJ-LETAL CR cap. 100mg (Cilostazol)Revoked2019-05-31Drug · Prescription · Approval201903651
- MFDS drugJ-LETAL CR cap. 200mg (Cilostazol)Revoked2019-05-31Drug · Prescription · Approval201903652
- MFDS drugPREFEPHEN Inj. (Acetaminophen)2019-05-21Drug · Prescription · Approval201903258
- MFDS drugCEFANAN Tab. (Cefpodoxime Proxetil)2019-03-22Drug · Prescription · Approval201901723
- MFDS drugJ.LOVA S tab. (Pelargonium Sidoides 11% Ethanol Dried Ext.(5.5~6.6→1))Revoked2018-08-28Drug · Prescription · Notification201803510
- MFDS drugNEODART Tab. (Dutasteride)2018-07-04Drug · Prescription · Approval201802794
- MFDS drugGLICOVER Tab. (Choline Alfoscerate)2018-06-27Drug · Prescription · Approval201802664
- MFDS drugClocover Tab. (Clopidogrel Bisulfate)Revoked2018-05-30Drug · Prescription · Approval201802249
- MFDS drugWELLMACO soft cap. (Omega-3-Acid Ethyl Esters 90)2018-03-23Drug · Prescription · Approval201801266
- MFDS drugJW Shinyak Levosulpiride Tab. (Levosulpiride)2018-03-15Drug · Prescription · Approval201801180
- MFDS drugJADE Tab. (R-Thioctic Acid Tromethamine)2018-01-29Drug · Prescription · Approval201800498
- MFDS drugJ-FEROL Inj. (Cholecalciferol)2017-12-13Drug · Prescription · Notification201708339
- MFDS drugJVASU Tab. 5mg2017-09-19Drug · Prescription · Approval201707146
- MFDS drugJVASU Tab. 20mg2017-09-19Drug · Prescription · Approval201707147
- MFDS drugJVASU Tab. 10mg2017-09-19Drug · Prescription · Approval201707148
- MFDS drugHIBEPO Tab. 10mg (Bepotastine Besilate)2017-08-23Drug · Prescription · Approval201706789
- MFDS drugCALLMEFLU Suspension Powder 6mg/mL (Oseltamivir Phosphate)2017-06-30Drug · Prescription · Approval201705153
- MFDS drugBALGRIA Tab. 100mg (Sildenafil Citrate)2017-06-19Drug · Prescription · Approval201704021
- MFDS drugBALGRIA Tab. 50mg (Sildenafil Citrate)2017-06-19Drug · Prescription · Approval201704022
- MFDS drugBALGNAFIL Tab. 5mg (Tadalafil)2017-06-16Drug · Prescription · Approval201703977
- MFDS drugBALGNAFIL Tab. 20mg (Tadalafil)Revoked2017-06-16Drug · Prescription · Approval201703978
- MFDS drugBALGNAFIL Tab. 10mg (Tadalafil)Revoked2017-06-16Drug · Prescription · Approval201703979
- MFDS drugNEOTUSS SR Tab. (Levodropropizine)2017-04-12Drug · Prescription · Approval201701834
- MFDS drugJW ShinyakAtorvastatin Tab. 20mg2017-03-15Drug · Prescription · Approval201701286
- MFDS drugJW ShinyakAtorvastatin Tab. 10mg2017-02-28Drug · Prescription · Approval201701097
- MFDS drugCALLMEFLU Cap. 75mg (Oseltamivir Phosphate)2017-02-27Drug · Prescription · Approval201701049
- MFDS drugTWYNTHERA tab. 40/5mg2016-09-30Drug · Prescription · Approval201605836
- MFDS drugTWYNTHERA tab. 80/5mg2016-09-30Drug · Prescription · Approval201605837
- MFDS drugTWYNTHERA tab. 40/10mg2016-09-30Drug · Prescription · Approval201605838
- MFDS drugGLICOVER Soft Cap. (Choline Alfoscerate)2016-06-15Drug · Prescription · Approval201603465
- MFDS drugJ-ryl Nail Lacquer (Amorolfine Hydrochloride)2016-05-11Drug · OTC · Notification201602591
- MFDS drugEPINALE Tab. (Epinastine Hydrochloride)2016-05-04Drug · Prescription · Approval201602513
- MFDS drugJ-COX Cap. 200mg (Celecoxib)Revoked2016-02-26Drug · Prescription · Approval201601082
- MFDS drugESIPLE-N Cap. (Bacillus Licheniformis)2016-01-20Drug · OTC · Notification201600361
- MFDS drugMONA S Cap.2015-11-25Drug · OTC · Notification201507900
- MFDS drugNEXIALDI Tab. 20mg (Esomeprazole Magnesium Trihydrate)2015-10-30Drug · Prescription · Approval201507477
- MFDS drugNEXIALDI Tab. 40mg (Esomeprazole Magnesium Trihydrate)2015-10-30Drug · Prescription · Approval201507478
- MFDS drugRABEROSE Tab. 10mg (Rabeprazole Sodium)2015-10-15Drug · Prescription · Approval201507195
- MFDS drugRABEROSE Tab. 20mg (Rabeprazole Sodium)2015-10-15Drug · Prescription · Approval201507196
- MFDS drugTRIMACET SEMI Tab.2015-09-17Drug · Prescription · Approval201506598
- MFDS drugXARIO OintmentRevoked2015-08-31Drug · Prescription · Approval201506191
- MFDS drugTRIMACET Tab.2015-07-30Drug · Prescription · Approval201505164
- MFDS drugMICARTELMI Tab. 40/12.5mg2015-06-08Drug · Prescription · Approval201503630
- MFDS drugMICARTELMI Tab. 80/12.5mg2015-06-08Drug · Prescription · Approval201503631
- MFDS drugCALYPHIL Tab. (Polycarbophil Calcium)Revoked2015-04-30Drug · Prescription · Approval201502656
Showing the 80 most recent of 184 records.
Clinical trials
data.go.kr19 MFDS clinical trial authorisations · 2012–2024 (Bioequivalence 18 · Phase 1 1)
- BioequivalenceJW06012024-06-27
2 trial sites
- BioequivalenceJW05012024-03-11
2 trial sites
- Phase 1JW01032023-09-27
2 trial sites
- BioequivalenceJW01032023-09-26
2 trial sites
- BioequivalenceJW04022023-03-10
2 trial sites
- BioequivalenceJW04012023-02-22
2 trial sites
- BioequivalenceJW01032022-06-28
1 trial site
- BioequivalenceJW01032022-06-24
1 trial site
- BioequivalenceHUC3-4702022-03-28
1 trial site
- Bioequivalence베스티딘정20밀리그램(파모티딘)2021-03-08
2 trial sites
- Bioequivalence피로이드정(피나스테리드)2020-08-11
2 trial sites
- Bioequivalence하이베포정10밀리그램(베포타스틴베실산염)2016-09-09
2 trial sites
Show 7 more
- Bioequivalence콜미플루캡슐75밀리그램(오셀타미비르인산염)2016-07-01
2 trial sites
- Bioequivalence레바큐어정(레바미피드)2014-05-27
2 trial sites
- Bioequivalence데소닉정0.2밀리그램(데소모프레신아세트산염)2013-12-27
2 trial sites
- Bioequivalence리스로마이신정(클래리트로마이신)2013-12-06
2 trial sites
- Bioequivalence제이더블유중외신약솔리페나신정10mg(솔리페나신숙신산염)(가칭)2013-10-29
2 trial sites
- Bioequivalence중외신약데스모프레신정0.2밀리그램(데스모프레신아세트산염)2012-12-20
- Bioequivalence팜슈어정250밀리그람(팜시클로버)2012-11-01
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
KOSPI-listed pharma/biotech company co-developing the autoimmune biologics batoclimab and imeropruvate with partner Immunovant.
KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
L&C BIO manufactures human tissue grafts across 11 tissue types, including the acellular dermal matrix MegaDerm, plus tissue-based medical devices.
KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Founded in 1962 and listed on the KOSPI in 1973, Yungjin Pharm is a KT&G Group pharmaceutical affiliate exporting antibiotic injectables and APIs and operating a CMO business.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition